TEXT SIZE a a a

William
New Video

Living With MS

MS Blog and Web Events

FDA Approves Ampyra

The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis.